However, AMOT, PDE11A, TYMS, and TMEM98 were distinctly expressed at elevated levels in the NAFLD-AF group compared to the other three groups of patients. This evidence concerns the gene PDE11A and metabolic dysfunction-associated steatotic liver disease.